Profil
Matthew Might is the founder of NGLY1.org.
He currently holds positions as an Independent Director at Q-State Biosciences, Inc. and as a Director at Q-State Holdings, Inc.
Aktive Positionen von Matthew Might
| Unternehmen | Position | Beginn |
|---|---|---|
Q-State Holdings, Inc.
 Q-State Holdings, Inc. BiotechnologyHealth Technology Q-State Holdings, Inc. provides biotechnology services. The company is headquartered in Cambridgem, MA. | Direktor/Vorstandsmitglied | - |
Q-State Biosciences, Inc.
 Q-State Biosciences, Inc. BiotechnologyHealth Technology Q-State Biosciences, Inc. operates as Biotechnology Company. It offers cardiology, neurology, toxicity screening, drug discovery, drug efficacy screening, pathology modeling, optogenetic, electrophysiology, voltage and calcium signal. The company was founded by Adam E. Cohen, Kevin Eggan, David Margulies and Joel Kralj and is headquartered in Cambridge, MA. | Direktor/Vorstandsmitglied | 16.11.2020 |
NGLY1.org
 NGLY1.org Miscellaneous Commercial ServicesCommercial Services NGLY1.org is a non-profit organization dedicated to advancing science in the service of patients, particularly those with NGLY1 deficiency. The organization is based in Salt Lake City, UT. The website provides an overview of Bertrand's life and legacy, including his advocacy for rare disease patients and his contributions to precision medicine. The Bertrand Might Endowment for Hope, a perpetual endowment at the University of Alabama at Birmingham, provides funding for individualized treatments for patients in need. The organization was founded by Matthew Might in honor of his son, Bertrand Might, who lived a remarkable life despite facing a constellation of symptoms from a young age. | Gründer | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
Q-State Biosciences, Inc.
Q-State Biosciences, Inc. BiotechnologyHealth Technology Q-State Biosciences, Inc. operates as Biotechnology Company. It offers cardiology, neurology, toxicity screening, drug discovery, drug efficacy screening, pathology modeling, optogenetic, electrophysiology, voltage and calcium signal. The company was founded by Adam E. Cohen, Kevin Eggan, David Margulies and Joel Kralj and is headquartered in Cambridge, MA. | Health Technology |
NGLY1.org
NGLY1.org Miscellaneous Commercial ServicesCommercial Services NGLY1.org is a non-profit organization dedicated to advancing science in the service of patients, particularly those with NGLY1 deficiency. The organization is based in Salt Lake City, UT. The website provides an overview of Bertrand's life and legacy, including his advocacy for rare disease patients and his contributions to precision medicine. The Bertrand Might Endowment for Hope, a perpetual endowment at the University of Alabama at Birmingham, provides funding for individualized treatments for patients in need. The organization was founded by Matthew Might in honor of his son, Bertrand Might, who lived a remarkable life despite facing a constellation of symptoms from a young age. | Commercial Services |
Q-State Holdings, Inc.
Q-State Holdings, Inc. BiotechnologyHealth Technology Q-State Holdings, Inc. provides biotechnology services. The company is headquartered in Cambridgem, MA. | Health Technology |
